The Ozempic lawsuit refers to thousands of personal injury lawsuits filed against Novo Nordisk, the manufacturer of Ozempic (semaglutide), by patients who allege the drug caused severe gastrointestinal injuries, including gastroparesis (stomach paralysis), and vision loss (NAION), without adequate warning
Target ranges may be slightly relaxed during the immediate post-operative period (typically 610 mmol/L), though this varies by procedure and individual factors
In theory, their mechanisms could be complementary rather than conflicting
GLP-1 and GIP receptors are expressed on various immune cells, including monocytes, macrophages, and lymphocytes
Zepbound may not be suitable for: Pregnant or breastfeeding individuals Those with a history of certain endocrine tumors At Frisco Quick Care, we believe that successful weight loss combines effective medication with a healthy diet and regular exercise